Botulinum Toxin Type A for the Treatment of Male Chronic Pelvic Pain Syndrome
Status:
Terminated
Trial end date:
2013-06-01
Target enrollment:
Participant gender:
Summary
The aim of this randomized placebo-controlled study is to demonstrate the efficiency and
safety of the injection of Botulinum Toxin Type A (200 Units) into the external urethral
sphincter for the treatment of chronic prostatitis/chronic pelvic pain.
Phase:
Phase 3
Details
Lead Sponsor:
Daniel Stephan Engeler
Collaborator:
Allergan
Treatments:
abobotulinumtoxinA Botulinum Toxins Botulinum Toxins, Type A incobotulinumtoxinA onabotulinumtoxinA